Syria’s First Lady To Withdraw From Public Duty To Treat Leukaemia – Presidency
Joy ChukwuMay 21, 20241 Mins read668 
Asma al-Assad, Syria’s first lady, has been diagnosed with leukaemia, the Syrian presidency announced in a statement on Tuesday.
“First Lady Asma al-Assad has been diagnosed with acute myeloid leukaemia,” the statement read.
It revealed that she “will undergo a specialised treatment protocol” that requires social distancing to avoid infection, adding that she will “temporarily withdraw from all direct engagements as part of her treatment plan”.
Acute myeloid leukaemia is an aggressive cancer of the bone marrow and the blood.
Assad has previously been treated for breast cancer. In August 2019, she announced that she was “completely” free of the disease a year after her diagnosis.
About The Author
Related Articles
Tinubu Demanded Jonathan’s Resignation in 2014—Why Is He Still in Office While Schoolgirls Are Kidnapped and Violence Spreads Nationwide?
The presidency of President Bola Ahmed Tinubu is going through one of...
Congo Extends Minerals Trade Ban in Conflict Zones as Pressure Mounts on Global Supply Chains
The Democratic Republic of Congo has extended its ban on the trade...
Benin Extends Presidential Term to Seven Years in Major Constitutional Overhaul
Benin has approved a sweeping constitutional reform that extends the presidential mandate...
Nigerian Army Denies ISWAP Claims After Militants Announce Killing of Brigadier General
Nigeria’s military is pushing back against claims by the Islamic State West...